SCHEMBL9924271

SCHEMBL9924271

O=C(/N=C(/NCc1ccc(F)cc1Cl)N[C@H]1CC[C@H](O)CC1)c1ccc(F)c(F)c1

nearest known ligand 0.43

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 19/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9924243 0.91 P2RX7 (0.39) P2RX7
SCHEMBL9924237 0.90 SIGMAR1 (0.39)
SCHEMBL9924272 0.89 P2RX7 (0.41) P2RX7
SCHEMBL9924065 0.88 P2RX7 (0.42) P2RX7
SCHEMBL9924245 0.87 EPHX2 (0.49) P2RX7
SCHEMBL9924242 0.85 LMNA (0.40)
SCHEMBL9924268 0.85 SSTR3 (0.46)
SCHEMBL17206627 0.84 KMT2A (0.42)
SCHEMBL9924426 0.84 EPHX1 (0.44)
SCHEMBL9924269 0.84 SSTR3 (0.45) P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
US-9169199-B2 Cycloalkyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof LYCERA CORPORATION (US) 2015-10-27 US disclosed
WO-2012078867-A2 CYCLOALKYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORPORATION (US) 2012-06-14 WO disclosed